Tapewire

Nasdaq · USD

ZNTL

Zentalis Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
5772
SEC CIK
0001725160
Parsed reports
252

Last 12 months

Inside the activity.

2 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202511
Jan 202600
Feb 202609
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2026 Filed Oct 2, 2026 01:19 UTC
Bruns IngmarChief Medical Officer
GrantCommon Stock 9,727 $2.18 $21,204.86
Disclosure

SEC source: 0001628280-26-064317 · wk-form4_1790889591.xml · nonDerivative · entry 1

Bruns Ingmar · CIK 0001838041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,059

F1 · kind: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2020 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of April 1, 2026 through September 30, 2026. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on April 1, 2026.

Read SEC document
August 14, 2026 Filed Aug 19, 2026 22:11 UTC
WALTERS GROUP10% owner
PurchaseCommon Stock 4,335,000 $3.50 $15,172,500.00
Disclosure

SEC source: 0001213900-26-091823 · ownership.xml · nonDerivative · entry 1

WALTERS GROUP · CIK 0001177523 · 10% owner

WALTERS WILLIAM THURMAN · CIK 0001689655 · 10% owner

WALTERS SUSAN BERKLEY · CIK 0001689761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,844,973

F1 · shares: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose.

F1 · balance_after: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose.

F1 · ownership.direct: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:09 UTC GrantCommon Stock 57,100 $0.00 $0.00
Disclosure

SEC source: 0001808098-26-000003 · wk-form4_1781813348.xml · nonDerivative · entry 1

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 307,521

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:08 UTC
Skvarka JanDirector
GrantCommon Stock 57,100 $0.00 $0.00
Disclosure

SEC source: 0001838042-26-000003 · wk-form4_1781813319.xml · nonDerivative · entry 1

Skvarka Jan · CIK 0001838042 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,254

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:07 UTC GrantCommon Stock 57,100 $0.00 $0.00
Disclosure

SEC source: 0001843119-26-000003 · wk-form4_1781813217.xml · nonDerivative · entry 1

Kariuki Enoch · CIK 0001843119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,465

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:07 UTC GrantCommon Stock 57,100 $0.00 $0.00
Disclosure

SEC source: 0001701440-26-000004 · wk-form4_1781813274.xml · nonDerivative · entry 1

Walker Luke Nathaniel · CIK 0001701440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,384

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:06 UTC GrantCommon Stock 57,100 $0.00 $0.00
Disclosure

SEC source: 0001356256-26-000005 · wk-form4_1781813168.xml · nonDerivative · entry 1

Myers Scott Dunseth · CIK 0001356256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 395,895

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
May 26, 2026 Filed May 27, 2026 20:11 UTC GrantCommon Stock 114,200 $0.00 $0.00
Disclosure

SEC source: 0002018966-26-000005 · wk-form4_1779912686.xml · nonDerivative · entry 1

Campbell Shannon · CIK 0002018966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,200

F1 · balance_after: The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 10, 2026 Filed Feb 11, 2026 02:10 UTC SaleCommon Stock 6,894 $2.42 $16,699.34
Disclosure

SEC source: 0002018766-26-000006 · wk-form4_1770775823.xml · nonDerivative · entry 3

Vultaggio Vincent · CIK 0002018766 · PAO and PFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,506

F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2025.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 02:10 UTC
Bruns IngmarChief Medical Officer
SaleCommon Stock 335 $2.39 $801.62
Disclosure

SEC source: 0001838041-26-000004 · wk-form4_1770775846.xml · nonDerivative · entry 2

Bruns Ingmar · CIK 0001838041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,332

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 02:10 UTC SaleCommon Stock 3,379 $2.39 $8,085.61
Disclosure

SEC source: 0002018766-26-000006 · wk-form4_1770775823.xml · nonDerivative · entry 2

Vultaggio Vincent · CIK 0002018766 · PAO and PFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 153,400

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 02:09 UTC
EASTLAND JULIA MARIEDirector · CEO & President
SaleCommon Stock 889 $2.39 $2,127.29
Disclosure

SEC source: 0001500189-26-000004 · wk-form4_1770775778.xml · nonDerivative · entry 2

EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,133

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
February 06, 2026 Filed Feb 11, 2026 02:10 UTC
Bruns IngmarChief Medical Officer
SaleCommon Stock 2,962 $2.43 $7,196.77
Disclosure

SEC source: 0001838041-26-000004 · wk-form4_1770775846.xml · nonDerivative · entry 1

Bruns Ingmar · CIK 0001838041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,667

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
February 06, 2026 Filed Feb 11, 2026 02:10 UTC SaleCommon Stock 29,951 $2.43 $72,771.94
Disclosure

SEC source: 0002018766-26-000006 · wk-form4_1770775823.xml · nonDerivative · entry 1

Vultaggio Vincent · CIK 0002018766 · PAO and PFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,779

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
February 06, 2026 Filed Feb 11, 2026 02:09 UTC
EASTLAND JULIA MARIEDirector · CEO & President
SaleCommon Stock 7,866 $2.43 $19,112.02
Disclosure

SEC source: 0001500189-26-000004 · wk-form4_1770775778.xml · nonDerivative · entry 1

EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,022

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 01:27 UTC SaleCommon Stock 556 $2.52 $1,398.34
Disclosure

SEC source: 0002018766-26-000004 · wk-form4_1770254867.xml · nonDerivative · entry 2

Vultaggio Vincent · CIK 0002018766 · PAO and PFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 186,730

F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person.

Read SEC document
February 02, 2026 Filed Feb 5, 2026 01:27 UTC SaleCommon Stock 2,540 $2.55 $6,477.00
Disclosure

SEC source: 0002018766-26-000004 · wk-form4_1770254867.xml · nonDerivative · entry 1

Vultaggio Vincent · CIK 0002018766 · PAO and PFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,286

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
January 08, 2026 Filed Jan 10, 2026 01:36 UTC GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $2.84 $0.00
Disclosure

SEC source: 0002018766-26-000002 · wk-form4_1768008966.xml · derivative · entry 1

Vultaggio Vincent · CIK 0002018766 · PAO and PFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Stock Option · 100,000 shares

Expires 2036-01-07

F1 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 08, 2026 Filed Jan 10, 2026 01:35 UTC
Bucher James BChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $2.84 $0.00
Disclosure

SEC source: 0001664928-26-000003 · wk-form4_1768008932.xml · derivative · entry 1

Bucher James B · CIK 0001664928 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-01-07

F1 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 08, 2026 Filed Jan 10, 2026 01:34 UTC
Bruns IngmarChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 365,000 $0.00 Strike: $2.84 $0.00
Disclosure

SEC source: 0001838041-26-000002 · wk-form4_1768008888.xml · derivative · entry 1

Bruns Ingmar · CIK 0001838041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,000

Underlying: Common Stock · 365,000 shares

Expires 2036-01-07

F1 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 08, 2026 Filed Jan 10, 2026 01:33 UTC
EASTLAND JULIA MARIEDirector · CEO & President
GrantStock Option (Right to Buy) · Derivative 775,000 $0.00 Strike: $2.84 $0.00
Disclosure

SEC source: 0001500189-26-000002 · wk-form4_1768008785.xml · derivative · entry 1

EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 775,000

Underlying: Common Stock · 775,000 shares

Expires 2036-01-07

F1 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 31, 2025 Filed Jan 8, 2026 21:57 UTC
WALTERS GROUP10% owner
PurchaseCommon Stock 6,459,973 $1.20 $7,751,967.60
Disclosure

SEC source: 0001213900-26-002567 · ownership.xml · nonDerivative · entry 1

WALTERS GROUP · CIK 0001177523 · 10% owner

WALTERS WILLIAM THURMAN · CIK 0001689655 · 10% owner

WALTERS SUSAN BERKLEY · CIK 0001689761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,509,973

F1 · shares: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose.

F1 · balance_after: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose.

F1 · ownership.direct: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose.

Read SEC document
December 15, 2025 Filed Dec 15, 2025 22:24 UTC
GOEL DAVID E.10% owner
SaleCommon Stock, par value $0.001 per share 7,500,000 $1.33 $9,975,000.00
Disclosure

SEC source: 0000902664-25-005288 · ownership.xml · nonDerivative · entry 1

Matrix Capital Management Company, LP · CIK 0001410830 · 10% owner

GOEL DAVID E. · CIK 0001548144 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 6,459,973

F1 · ownership.nature: The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.

F2 · ownership.nature: The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Read SEC document
October 01, 2025 Filed Oct 1, 2025 22:40 UTC
Bucher James BChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 400,000 $0.00 Strike: $1.54 $0.00
Disclosure

SEC source: 0001664928-25-000008 · wk-form4_1759358422.xml · derivative · entry 1

Bucher James B · CIK 0001664928 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2025-09-30

F1 · derivative.exercise_date: The options will vest over a four-year period as follows: 25% of the options will vest on October 1, 2026, with the remaining 75% vesting in substantially equal monthly installments thereafter until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:15 UTC GrantCommon Stock 57,603 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000133 · wk-form4_1750277742.xml · nonDerivative · entry 1

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,421

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:19 UTC GrantCommon Stock 57,603 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000137 · wk-form4_1750277940.xml · nonDerivative · entry 1

Walker Luke Nathaniel · CIK 0001701440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,284

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:17 UTC
Skvarka JanDirector
GrantCommon Stock 57,603 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000135 · wk-form4_1750277814.xml · nonDerivative · entry 1

Skvarka Jan · CIK 0001838042 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,154

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:14 UTC GrantCommon Stock 57,603 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000131 · wk-form4_1750277634.xml · nonDerivative · entry 1

Kariuki Enoch · CIK 0001843119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,365

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:12 UTC GrantCommon Stock 57,603 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000129 · wk-form4_1750277537.xml · nonDerivative · entry 1

Myers Scott Dunseth · CIK 0001356256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,795

F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.

Read SEC document
April 30, 2025 Filed Apr 30, 2025 21:07 UTC PurchaseCommon Stock 21,000 $1.40 $29,372.70
Disclosure

SEC source: 0001725160-25-000094 · wk-form4_1746047232.xml · nonDerivative · entry 1

Myers Scott Dunseth · CIK 0001356256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,192

Read SEC document
February 06, 2025 Filed Feb 12, 2025 22:00 UTC
Bruns IngmarChief Medical Officer
PurchaseCommon Stock 20,000 $2.28 $45,656.00
Disclosure

SEC source: 0001725160-25-000047 · wk-form4_1739397624.xml · nonDerivative · entry 1

Bruns Ingmar · CIK 0001838041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,629

Read SEC document
February 03, 2025 Filed Feb 5, 2025 18:31 UTC
Paul AndreaChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 124,714 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001725160-25-000040 · wk-form4_1738798313.xml · derivative · entry 3

Paul Andrea · CIK 0001863130 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,714

Underlying: Common Stock · 124,714 shares

Expires 2035-02-02

F3 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 18:31 UTC
Paul AndreaChief Legal Officer
SaleCommon Stock 13,230 $1.71 $22,643.15
Disclosure

SEC source: 0001725160-25-000040 · wk-form4_1738798313.xml · nonDerivative · entry 2

Paul Andrea · CIK 0001863130 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,070,784

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 18:31 UTC
Paul AndreaChief Legal Officer
GrantCommon Stock 934,041 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000040 · wk-form4_1738798313.xml · nonDerivative · entry 1

Paul Andrea · CIK 0001863130 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,084,014

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:33 UTC
Vultaggio VincentPAO and Interim PFO
GrantStock Option (Right to Buy) · Derivative 35,633 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001725160-25-000043 · wk-form4_1738798376.xml · derivative · entry 3

Vultaggio Vincent · CIK 0002018766 · PAO and Interim PFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,633

Underlying: Common Stock · 35,633 shares

Expires 2035-02-02

F3 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:33 UTC
Vultaggio VincentPAO and Interim PFO
SaleCommon Stock 2,615 $1.71 $4,475.57
Disclosure

SEC source: 0001725160-25-000043 · wk-form4_1738798376.xml · nonDerivative · entry 2

Vultaggio Vincent · CIK 0002018766 · PAO and Interim PFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,826

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:33 UTC
Vultaggio VincentPAO and Interim PFO
GrantCommon Stock 158,586 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000043 · wk-form4_1738798376.xml · nonDerivative · entry 1

Vultaggio Vincent · CIK 0002018766 · PAO and Interim PFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,441

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:32 UTC
Lackner MarkChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 124,714 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001725160-25-000041 · wk-form4_1738798344.xml · derivative · entry 3

Lackner Mark · CIK 0001777413 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,714

Underlying: Common Stock · 124,714 shares

Expires 2035-02-02

F3 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:32 UTC
Lackner MarkChief Scientific Officer
SaleCommon Stock 14,368 $1.71 $24,590.83
Disclosure

SEC source: 0001725160-25-000041 · wk-form4_1738798344.xml · nonDerivative · entry 2

Lackner Mark · CIK 0001777413 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 512,856

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:32 UTC
Lackner MarkChief Scientific Officer
GrantCommon Stock 335,907 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000041 · wk-form4_1738798344.xml · nonDerivative · entry 1

Lackner Mark · CIK 0001777413 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 527,224

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:29 UTC
EASTLAND JULIA MARIEDirector · CEO & President
GrantStock Option (Right to Buy) · Derivative 59,388 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001725160-25-000036 · wk-form4_1738798191.xml · derivative · entry 2

EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,388

Underlying: Common Stock · 59,388 shares

Expires 2035-02-02

F2 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:29 UTC
EASTLAND JULIA MARIEDirector · CEO & President
GrantCommon Stock 59,388 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000036 · wk-form4_1738798191.xml · nonDerivative · entry 1

EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,888

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:30 UTC
Bruns IngmarChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 16,629 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001725160-25-000037 · wk-form4_1738798229.xml · derivative · entry 2

Bruns Ingmar · CIK 0001838041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,629

Underlying: Common Stock · 16,629 shares

Expires 2035-02-02

F2 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:30 UTC
Bruns IngmarChief Medical Officer
GrantCommon Stock 16,629 $0.00 $0.00
Disclosure

SEC source: 0001725160-25-000037 · wk-form4_1738798229.xml · nonDerivative · entry 1

Bruns Ingmar · CIK 0001838041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,629

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 21:45 UTC
Skvarka JanDirector
PurchaseCommon Stock 60,000 $1.72 $103,446.00
Disclosure

SEC source: 0001725160-25-000030 · wk-form4_1738705494.xml · nonDerivative · entry 1

Skvarka Jan · CIK 0001838042 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,551

Read SEC document
January 31, 2025 Filed Feb 4, 2025 21:43 UTC PurchaseCommon Stock 14,200 $1.76 $24,966.44
Disclosure

SEC source: 0001725160-25-000029 · wk-form4_1738705431.xml · nonDerivative · entry 1

Walker Luke Nathaniel · CIK 0001701440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,681

Read SEC document
January 31, 2025 Filed Feb 4, 2025 21:37 UTC
EASTLAND JULIA MARIEDirector · CEO & President
PurchaseCommon Stock 28,500 $1.73 $49,344.90
Disclosure

SEC source: 0001725160-25-000028 · wk-form4_1738705022.xml · nonDerivative · entry 1

EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

Read SEC document
January 02, 2025 Filed Jan 3, 2025 22:17 UTC
Lackner MarkChief Scientific Officer
SaleCommon Stock 4,411 $3.12 $13,762.32
Disclosure

SEC source: 0001725160-25-000002 · wk-form4_1735942617.xml · nonDerivative · entry 1

Lackner Mark · CIK 0001777413 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,317

F1 · kind: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 00:02 UTC
Bruns IngmarChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 712,650 $0.00 Strike: $3.66 $0.00
Disclosure

SEC source: 0001725160-24-000190 · wk-form4_1733270555.xml · derivative · entry 1

Bruns Ingmar · CIK 0001838041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 712,650

Underlying: Common Stock · 712,650 shares

Expires 2034-12-02

F1 · derivative.exercise_date: The options will vest over a four-year period as follows: 25% of the options will vest on November 13, 2025, with the remaining 75% vesting in substantially equal monthly installments thereafter until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 00:02 UTC
EASTLAND JULIA MARIEDirector · CEO & President
GrantStock Option (Right to Buy) · Derivative 3,028,800 $0.00 Strike: $3.66 $0.00
Disclosure

SEC source: 0001725160-24-000189 · wk-form4_1733270528.xml · derivative · entry 1

EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,028,800

Underlying: Common Stock · 3,028,800 shares

Expires 2034-12-02

F1 · derivative.exercise_date: The options will vest over a four-year period following the vesting commencement date of November 13, 2024, in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.